Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
Title : Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis - Khan_2023_Front.Immunol_14_1269261 |
Author(s) : Khan MAH , Nolan B , Stavniichuk A , Merk D , Imig JD |
Ref : Front Immunol , 14 :1269261 , 2023 |
Abstract : Khan_2023_Front.Immunol_14_1269261 |
ESTHER : Khan_2023_Front.Immunol_14_1269261 |
PubMedSearch : Khan_2023_Front.Immunol_14_1269261 |
PubMedID: 38235144 |
Title : Dual sEH\/COX-2 Inhibition Using PTUPB-A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity - Jankiewicz_2021_Front.Pharmacol_12_744776 |
Author(s) : Jankiewicz WK , Barnett SD , Stavniichuk A , Hwang SH , Hammock BD , Belayet JB , Khan AH , Imig JD |
Ref : Front Pharmacol , 12 :744776 , 2021 |
Abstract : Jankiewicz_2021_Front.Pharmacol_12_744776 |
ESTHER : Jankiewicz_2021_Front.Pharmacol_12_744776 |
PubMedSearch : Jankiewicz_2021_Front.Pharmacol_12_744776 |
PubMedID: 34955823 |
Title : Multitarget molecule,PTUPB, to treat diabetic nephropathy in rats - Hye_2021_Br.J.Pharmacol_178_4468 |
Author(s) : Hye Khan MA , Hwang SH , Barnett SD , Stavniichuk A , Jankiewicz WK , Hammock BD , Imig JD |
Ref : British Journal of Pharmacology , 178 :4468 , 2021 |
Abstract : Hye_2021_Br.J.Pharmacol_178_4468 |
ESTHER : Hye_2021_Br.J.Pharmacol_178_4468 |
PubMedSearch : Hye_2021_Br.J.Pharmacol_178_4468 |
PubMedID: 34255857 |
Title : Dual Soluble Epoxide Hydrolase Inhibitor\/PPAR-gamma Agonist Attenuates Renal Fibrosis - Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472 |
Author(s) : Stavniichuk A , Hye Khan MA , Yeboah MM , Chesnik MA , Jankiewicz WK , Hartmann M , Blocher R , Kircher T , Savchuk O , Proschak E , Imig JD |
Ref : Prostaglandins Other Lipid Mediat , :106472 , 2020 |
Abstract : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472 |
ESTHER : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472 |
PubMedSearch : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472 |
PubMedID: 32569747 |
Title : A dual farnesoid X receptor\/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice - Hye_2019_Biochem.Pharmacol_166_212 |
Author(s) : Hye Khan MA , Schmidt J , Stavniichuk A , Imig JD , Merk D |
Ref : Biochemical Pharmacology , 166 :212 , 2019 |
Abstract : Hye_2019_Biochem.Pharmacol_166_212 |
ESTHER : Hye_2019_Biochem.Pharmacol_166_212 |
PubMedSearch : Hye_2019_Biochem.Pharmacol_166_212 |
PubMedID: 31129048 |